Sotera Health (SHC) Expected to Announce Quarterly Earnings on Friday

Key Points

• Sotera Health will announce its Q2 2025 earnings on August 4th, with expectations for $0.17 earnings per share and $275.81 million in revenue.
• The company previously reported $0.14 earnings per share for Q1 2025, surpassing estimates, and had a revenue growth of 2.6% year-over-year.
• Sotera Health's current stock price is $12.30, with a consensus price target of $16.00 and ratings indicating a Moderate Buy from analysts.

Sotera Health (NASDAQ:SHC - Get Free Report) is projected to post its Q2 2025 quarterly earnings results before the market opens on Friday, August 8th. Analysts expect Sotera Health to post earnings of $0.17 per share and revenue of $275.81 million for the quarter.

Sotera Health (NASDAQ:SHC - Get Free Report) last announced its earnings results on Thursday, May 1st. The company reported $0.14 EPS for the quarter, beating analysts' consensus estimates of $0.12 by $0.02. The company had revenue of $254.52 million during the quarter, compared to the consensus estimate of $245.56 million. Sotera Health had a return on equity of 41.08% and a net margin of 2.24%. The firm's revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.13 earnings per share. On average, analysts expect Sotera Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Sotera Health Stock Down 3.6%

SHC traded down $0.43 during trading on Thursday, reaching $11.49. The stock had a trading volume of 236,064 shares, compared to its average volume of 1,173,392. The stock's 50 day moving average is $11.72 and its two-hundred day moving average is $12.10. The company has a current ratio of 2.46, a quick ratio of 2.19 and a debt-to-equity ratio of 5.55. The company has a market capitalization of $3.26 billion, a price-to-earnings ratio of 144.06 and a beta of 1.81. Sotera Health has a one year low of $9.53 and a one year high of $17.08.

Institutional Trading of Sotera Health

A number of hedge funds have recently modified their holdings of SHC. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Sotera Health by 14.5% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company's stock valued at $3,999,000 after purchasing an additional 43,471 shares during the last quarter. Empowered Funds LLC increased its holdings in shares of Sotera Health by 11.1% in the first quarter. Empowered Funds LLC now owns 28,512 shares of the company's stock valued at $332,000 after purchasing an additional 2,845 shares during the last quarter. Finally, Acadian Asset Management LLC increased its stake in Sotera Health by 125.5% during the first quarter. Acadian Asset Management LLC now owns 25,192 shares of the company's stock worth $293,000 after acquiring an additional 14,018 shares during the last quarter. Hedge funds and other institutional investors own 91.03% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on SHC shares. Wall Street Zen raised Sotera Health from a "hold" rating to a "buy" rating in a research note on Saturday, June 28th. Barclays lowered their target price on Sotera Health from $15.00 to $13.00 and set an "overweight" rating on the stock in a report on Tuesday, June 24th. Piper Sandler decreased their price objective on Sotera Health from $15.00 to $13.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 23rd. Finally, The Goldman Sachs Group raised Sotera Health from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $14.00 to $17.00 in a research note on Monday, May 5th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $16.00.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.